The National Comprehensive Cancer Network (NCCN) is pleased to be participating in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO).
XI’AN, China, Nov. 15, 2024 — The National Comprehensive Cancer Network® (NCCN®), a leading US cancer center alliance, is attending the Fourth International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO). This three-day event, sponsored by the China Anti-Cancer Association (CACA), Chinese Institute of Development Strategy on Holistic Integrative Medicine, and Asian Oncology Society (AOS), focuses on global collaborations to enhance cancer care and outcomes in China and beyond.
“NCCN is honored to be part of this significant event,” stated Wui-Jin Koh, MD, Chief Medical Officer, NCCN. “China ranks among the top three nations globally in website user registrations and NCCN Guidelines downloads. We are thankful that our evidence-based, expert consensus recommendations are used to improve cancer care across China and Asia.”
The NCCN Clinical Practice Guidelines in Oncology (®) help establish and advance high-quality, high-value, patient-centered cancer care worldwide. The 88 NCCN Guidelines® provide multi-disciplinary expert panel recommendations for treating nearly all cancer types, along with screening, prevention, and supportive care. They are the most comprehensive and frequently updated clinical practice guidelines in medicine. Worldwide, NCCN Guidelines had over 15 million downloads in 2023, with nearly a million from China alone.
NCCN has made significant progress recently in boosting global access to and relevance of NCCN Guidelines to help improve the lives of cancer patients. NCCN is delighted to collaborate with leading oncology organizations in China, including:
- Chinese Gynecologic Cancer Society (CGCS) and Shanghai Yanxin Cultural Firm
- This ongoing collaboration involves working with leading Chinese gynecologic experts to translate, adapt, and update NCCN Guidelines for Gynecologic Cancers, encompassing Cervical Cancer, Gestational Trophoblastic Neoplasia, Ovarian Cancer, Uterine Neoplasms, and Vulvar Cancer.
- Medlive
- This partnership facilitates NCCN Guidelines dissemination in English and Chinese via Medlive’s computer, smartphone, and tablet platforms.
NCCN resources are freely available globally, including to over 100,000 registered users in China. NCCN Guidelines have been translated over 250 times into roughly 50 languages, with 30 in Chinese. The NCCN Global Program also offers free access to International Adaptations, NCCN Framework for Resource Stratification (NCCN Framework
), and NCCN Harmonized Guidelines, which provide practical approaches to determining appropriate, regionally tailored treatment. Learn more and access these materials at .
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a non-profit alliance of leading cancer centers dedicated to patient care, research, and education. NCCN strives to improve and facilitate high-quality, effective, equitable, and accessible cancer care so all patients can experience better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they serve as the recognized standard for clinical direction and policy in cancer management and are the most thorough and frequently-updated clinical practice guidelines in medicine. The NCCN Guidelines for Patients® offer expert cancer treatment information to inform and empower patients and caregivers, with support from the NCCN Foundation®. NCCN also promotes continuing education, global initiatives, policy, and collaborative research and publication in oncology. Visit for more information.
Media Contact:
Rachel Darwin
267-622-6624
Logo –
“`